(4R)-4-hydroxy-N-[[2-[2-[2-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide
C49H54N6O7S2 — CID 155091328
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R)-4-hydroxy-N-[[2-[2-[2-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide
(4R)-4-hydroxy-N-[[2-[2-[2-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide (PubChem CID 155091328) has the molecular formula C49H54N6O7S2 and a molecular weight of 903.14 g/mol. Its IUPAC name is (4R)-4-hydroxy-N-[[2-[2-[2-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (4R)-4-hydroxy-N-[[2-[2-[2-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 155091328 |
| Molecular Formula | C49H54N6O7S2 |
| Molecular Weight | 903.14 g/mol |
| Exact Mass | 902.35 |
| IUPAC Name | (4R)-4-hydroxy-N-[[2-[2-[2-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide |
| SMILES | Cc1ccc2nc(-c3ccc(NCCOCCOCCOc4cc(-c5scnc5C)ccc4CNC(=O)C4C[C@@H](O)CN4C(=O)[C@H](C(C)C)N4Cc5ccccc5C4=O)cc3)sc2c1 |
| InChI | InChI=1S/C49H54N6O7S2/c1-30(2)44(55-27-36-7-5-6-8-39(36)48(55)58)49(59)54-28-38(56)25-41(54)46(57)51-26-35-11-10-34(45-32(4)52-29-63-45)24-42(35)62-22-21-61-20-19-60-18-17-50-37-14-12-33(13-15-37)47-53-40-16-9-31(3)23-43(40)64-47/h5-16,23-24,29-30,38,41,44,50,56H,17-22,25-28H2,1-4H3,(H,51,57)/t38-,41?,44+/m1/s1 |
| InChIKey | VNNUDYNLVCRMPW-WJKXTPDSSA-N |
| XLogP | 7.49 |
| TPSA | 155.45 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 64 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 903.14 |
| LogP ≤ 5 | 7.49 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 12 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155091328 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.